International Journal of Molecular Medical Science, 2025, Vol.15, No.6, 298-309 http://medscipublisher.com/index.php/ijmms 308 Rusch J., Layden B., and Dugas L., 2023, Signalling cognition: the gut microbiota and hypothalamic-pituitary-adrenal axis, Frontiers in Endocrinology, 14: 1130689. https://doi.org/10.3389/fendo.2023.1130689 Salim S., Ahmad F., Banu A., and Mohammad F., 2022, Gut microbiome and Parkinson's disease: perspective on pathogenesis and treatment, Journal of Advanced Research, 50: 83-105. https://doi.org/10.1016/j.jare.2022.10.013 Santos J., Lima M., Brito G., and Viana G., 2022, Role of enteric glia and microbiota-gut-brain axis in parkinson disease pathogenesis, Ageing Research Reviews, 84: 101812. https://doi.org/10.1016/j.arr.2022.101812 Simon D., Tanner C., and Brundin P., 2020, Parkinson disease epidemiology pathology genetics and pathophysiology, Clinics in Geriatric Medicine, 36(1): 1-12. https://doi.org/10.1016/j.cger.2019.08.002 Singh S., Raj K., Chib S., and Mallan S., 2022, Microbiota- brain-gut-axis relevance to parkinson's disease: potential therapeutic effects of probiotics, Current Pharmaceutical Design, 28(37): 3049-3067. https://doi.org/10.2174/1381612828666221003112300 Skjærbæk C., Knudsen K., Horsager J., and Borghammer P., 2021, Gastrointestinal dysfunction in Parkinson’s disease, Journal of Clinical Medicine, 14(6): 625-639. https://doi.org/10.3390/jcm10030493 Sobral J., Empadinhas N., Esteves A., and Cardoso S., 2025, Impact of nutrition on the gut microbiota: implications for Parkinson's disease, Nutrition Reviews, 83(4): 713-727. https://doi.org/10.1093/nutrit/nuae208 Suganya K., and Koo B., 2020, Gut–brain axis: role of gut microbiota on neurological disorders and how probiotics/prebiotics beneficially modulate microbial and immune pathways to improve brain functions, International Journal of Molecular Sciences, 21(20): 7551. https://doi.org/10.3390/ijms21207551 Tan A., Chong C., Lim S., Yap I., Teh C., Loke M., Song S., Tan J., Ang B., Tan Y., Kho M., Bowman J., Mahadeva S., Yong H., and Lang A., 2020, Gut microbial ecosystem in Parkinson disease: new clinicobiological insights from multi‐omics, Annals of Neurology, 89(3): 546-559. https://doi.org/10.1002/ana.25982 Tan A., Lim S., and Lang A., 2022, The microbiome–gut–brain axis in Parkinson disease-from basic research to the clinic, Nature Reviews Neurology, 18: 476-495. https://doi.org/10.1038/s41582-022-00681-2 Wang Q., Luo Y., Chaudhuri K., Reynolds R., Tan E., and Pettersson S., 2021, The role of gut dysbiosis in Parkinson's disease: mechanistic insights andtherapeutic options, Brain, 144(9): 2571-2593. https://doi.org/10.1093/brain/awab156 Xu D., Yong C., Yang X., Chen-Yu S., and Peng L., 2023, Signaling pathways in Parkinson’s disease: molecular mechanisms and therapeutic interventions, Signal Transduction and Targeted Therapy, 8(1): 73. https://doi.org/10.1038/s41392-023-01353-3 Yadav S., and Raj R., 2025, Parkinson’s disease and the gut microbiota connection: unveiling dysbiosis and exploring therapeutic horizons, Neuroscience, 581: S0306-4522. https://doi.org/10.1016/j.neuroscience.2025.07.003 Yang R., Jia M., Xu Y., Wu Z., Wu D., Fan G., and Gui Y., 2025, Microbiome and metabolome integrated analysis: exploring potential diagnostic approaches for Parkinson’s disease using tongue coating samples, Frontiers in Microbiology 16: 1621468. https://doi.org/10.3389/fmicb.2025.1621468 Yao L., Yang Y., Yang X., and Rezaei M., 2024, The interaction between nutraceuticals and gut microbiota: a novel therapeutic approach to prevent and treatment Parkinson's disease, Molecular Neurobiology, 61(11): 9078-9109. https://doi.org/10.1007/s12035-024-04151-2 Yu B., Zhang H., and Zhang M., 2025, Deep learning-based differential gut flora for prediction of Parkinson’s, PLOS ONE, 20(1): e0310005. https://doi.org/10.1371/journal.pone.0310005 Zhao Z., Chen J., Zhao D., Chen B., Wang Q., Li Y., Chen J., Bai C., Guo X., Hu N., Zhang B., Zhao R., and Yuan J., 2024, Microbial biomarker discovery in Parkinson’s disease through a network-based approach, NPJ Parkinson's Disease, 10(1): 203. https://doi.org/10.1038/s41531-024-00802-2 Zhao Z., Ning J., Bao X., Shang M., Ma J., Li G., and Zhang D., 2021, Fecal microbiota transplantation protects rotenone-induced Parkinson’s disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis, Microbiome, 9(1): 226. https://doi.org/10.1186/s40168-021-01107-9 Zheng Y., Bonfili L., Wei T., and Eleuteri A., 2023, Understanding the gut–brain axis and its therapeutic implications for neurodegenerative disorders, Nutrients, 15(21): 4631. https://doi.org/10.3390/nu15214631
RkJQdWJsaXNoZXIy MjQ4ODYzNA==